Blood Culture Test Market worth $4,768.9 million by 2021 | Becton, Dickinson and Company (U.S.), bioMérieux SA (France), and Thermo Fisher Scientific, Inc. (U.S.)

According to latest research report "Blood Culture Test Market Size & Share by Application (Bacteremia, Fungemia), Product (Consumables, Instrument), Method (Automated, Manual), Technology (PCR, Microarray, Proteomic) & End User (Hospital Laboratories, Reference Laboratories) - Global Forecast to 2021", the overall market of blood culture test is projected to reach $4,768.9 million by 2021 from $3,252.6 million in 2016, at a CAGR of 8.0%. Factors such as rapidly rising aging population, increase in product approvals and launches, high incidence of bloodstream infections, high prevalence of infectious diseases, and increase in demand for rapid diagnostic techniques are driving the growth of the blood culture test market during the forecast period.

Browse 300 market data Tables and 50 Figures spread through 249 Pages and in-depth TOC on "Blood Culture Test Market"
https://www.marketsandmarkets.com/Market-Reports/blood-culture-test-market-159606753.html

In this report, the overall market of blood culture test is segmented on the basis of method, product, technology, application, end user, and region. Based on end user, the market of blood culture test is segmented into hospital laboratories, reference laboratories, academic research laboratories, and other laboratories (pathology laboratories, bacteriological laboratories, physician office laboratories (POLs), and independent research laboratories). The reference laboratories segment is expected to grow at the highest CAGR during the forecast period. The high growth of this segment is attributed to the increasing outsourcing of blood culture tests by hospitals to reference laboratories, as they can perform a large volume of tests and are equipped with advanced diagnostic techniques that provide blood culture test with a quick turnaround time.

Early buyers will receive 10% customization on reports.
Get 10% FREE Customization on this report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=159606753&utm_source=OpenPR_23_Jan_2019&utm_medium=Paid-PR

Geographically, the market of blood culture test is segmented into North America, Europe, Asia, and the Rest of the World (RoW). In 2016, North America is expected to account for the largest share of the blood culture test market. However, the Asian market is expected to grow at the highest CAGR. Growth in the Asian market can be attributed to the high incidence of sepsis and government initiatives to increase awareness on the disease, increasing demand for effective diagnostic techniques, rising awareness about early disease diagnosis, increasing adoption of advanced technologies, rapid rise in geriatric population, and growing regulatory approvals & availability of blood culture test products in this region.

The blood culture test market is highly competitive, with prominent players such as Becton, Dickinson and Company (U.S.), bioMérieux SA (France), and Thermo Fisher Scientific, Inc. (U.S.). Some of the other players in this market include Cepheid, Inc. (U.S.), Nanosphere, Inc. (U.S.), IRIDICA (U.S.), Beckman Coulter (U.S.), Bruker Corporation (U.S.), and T2 Biosystems (U.S.).

Read More: https://www.marketsandmarkets.com/PressReleases/blood-culture-test.asp
Research Insight: https://www.marketsandmarkets.com/ResearchInsight/blood-culture-test-market.asp

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth emerging opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model - GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets's™ flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : +1-888-600-6441

UK : +44-800-368-9399
sales@marketsandmarkets.com

This release was published on openPR.